A new open-access review in Ferroptosis and Oxidative Stress argues that ZBP1 can function as an innate immune sensor linking genomic damage to antitumor immune activation. The authors propose that intentionally triggering the ZBP1 pathway could help convert immunologically “cold” tumors into “hot” ones, potentially expanding the contexts where immunotherapy works better. The paper positions ZBP1 within a broader innate immune framework, focusing on how stress signals from damaged nucleic acids can shape immune recognition inside tumors. While described as a conceptual roadmap rather than new clinical outcomes, the review highlights actionable pathway logic for future translational experiments. For developers of immuno-oncology combinations, the report adds a mechanistic basis for exploring pharmacologic approaches that engage ZBP1-related signaling as a way to sensitize tumors to checkpoint blockade.